Cargando…
Among patients with advanced ovarian carcinoma, who benefits from bevacizumab the most?
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477662/ https://www.ncbi.nlm.nih.gov/pubmed/37675330 http://dx.doi.org/10.21037/atm-23-903 |